AS
Alec Stranahan B of A Securities Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Candel Therapeutics
CADL
$268M
| $4.89 | $7 |
43%
upside
| Neutral | yesterday |
|
2 |
2
Xencor
XNCR
$597M
| $8.37 | $12 |
43%
upside
| Neutral | yesterday |
|
3 |
3
Erasca
ERAS
$420M
| $1.48 | $1 |
32%
downside
| Underperform | yesterday |
|
4 |
4
Novavax
NVAX
$1.27B
| $7.79 | $7 |
10%
downside
| Underperform | 15 days ago |
|
5 |
5
Krystal Biotech
KRYS
$4.33B
| $149.75 | $192 |
28%
upside
| Buy | 1 month ago |
|
6 |
6
Beam Therapeutics
BEAM
$1.88B
| $18.54 | $42 |
127%
upside
| Buy | 5 months ago |
|
7 |
7
Y-mAbs Therapeutics
YMAB
$389M
| $8.57 | $12 |
40%
upside
| Neutral | 6 months ago |
|
8 |
8
Day One Biopharmaceuticals
DAWN
$759M
| $7.41 | $25 |
237%
upside
| Buy | 8 months ago |
|
9 |
9
Perspective Therapeutics
CATX
$263M
| $3.54 | $6 |
69%
upside
| Neutral | 9 months ago |
|
10 |
10
Revolution Medicines
RVMD
$7.28B
| $38.95 | $55 |
41%
upside
| Buy | 1 year ago |
|
11 |
11
TG Therapeutics
TGTX
$5.06B
| $31.89 | $6 |
81%
downside
| Underperform | 2 years ago |
|